- Megan Paquin

Choose the health content that’s right for you, and get it delivered right in your inbox.
The AdventHealth Neuroscience Institute is celebrating a new designation as one of only 20 ELITE GammaTile Centers in the U.S. This recognition comes as the institute’s neurosurgeons and oncologists have successfully completed 10 GammaTile procedures since becoming the first in Central Florida to treat aggressive brain tumors with this advanced technology.
GammaTile Therapy is a novel Surgically Targeted Radiation Therapy (STaRT) for operable brain tumors. Implanted in the last five minutes of brain tumor removal surgery, each bioresorbable, 3D-collagen GammaTile is embedded with radiation sources. GammaTile Therapy delivers a sustained, controlled, therapeutic radiation dose, targeting tumor cells while sparing healthy tissue.

“Our commitment to complete, whole-person neurological care begins with our world-class specialists who consistently seek out leading-edge therapies for our patients,” said Craig Brubaker, vice president of AdventHealth’s Neuroscience Institute. “This milestone exemplifies their dedication, and we are pleased to be able to bring this advanced level of brain care to residents of this community.”
Dr. Melvin Field added, “This innovation is giving our patients a head-start in the fight against brain tumors. With GammaTile, we can immediately and precisely target cancer-involved tissues with a high dose of radiation, potentially extending our patients lives and helping maintain a higher quality of life throughout their treatment.”
In the past 50 years, only seven drugs or devices have been FDA-approved or -cleared to treat brain tumors. The latest advancement in brain tumor treatment, GammaTile Therapy was FDA-cleared in 2018 for recurrent brain tumors, including recurrent high-grade gliomas, glioblastomas, meningiomas and brain metastases. In 2020, the FDA expanded that indication to include newly diagnosed malignant brain tumors. For more information, visit the AdventHealth Neuroscience Institute’s brain tumor program here.
Recent News
A nurse at AdventHealth Palm Coast surprised a colleague with an extraordinary gift: a car.
Baby Mattie needed a liver transplant but was too sick to even get on the list. For the nurses at AdventHealth for Children, it became their mission to save her.
Nine-month-old Mattie was in a coma, her organs were shutting down and her little body was fighting a battle that seemed insurmountable. For the nurses at AdventHealth for Children, it became their...
AdventHealth is expanding its nursing workforce, enhancing hands-on training programs and reinforcing its commitment to exceptional patient care.
AdventHealth Carrollwood has been awarded an “A” Hospital Safety Grade by The Leapfrog Group, a national nonprofit upholding the standard of excellence in patient safety in hospitals and ambulatory...
Dozens of community members and several organizations came together to help support the AdventHealth Lake Placid and Wauchula Foundations during the 11th annual Clays and Camo fundraiser. This event...
The spring 2025 Leapfrog grades have been released, and four AdventHealth Rocky Mountain Region hospitals have achieved top honors for patient safety!
AdventHealth North Pinellas achieves elite national status as a straight- ‘A’ for patient safety
All AdventHealth hospitals in Pasco County continue to earn straight ‘A’ hospital safety grades from The Leapfrog Group.
Three UChicago Medicine AdventHealth hospitals have earned “A” safety grades from The Leapfrog Group, ranking among the safest hospitals in the nation.
AdventHealth Lake Wales Earns Elite National Status as an ‘A’ for Patient Safety
AdventHealth Ocala achieves elite national status as a straight ‘A’ for patient safety